CompletedPHASE1, PHASE2NCT03913806

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW

Studying Soft tissue sarcoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Medical Center Groningen
Principal Investigator
Gooitzen van Dam, MD, PhD
University Medical Center Groningen
Intervention
Bevacizumab-IRDye800CW(drug)
Enrollment
16 target
Eligibility
18 years · All sexes
Timeline
20182020

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03913806 on ClinicalTrials.gov

Other trials for Soft tissue sarcoma

Additional recruiting or active studies for the same condition.

See all trials for Soft tissue sarcoma

← Back to all trials